About Soy Allergy
Soybeans are a member of the legume family. Soy allergy is more common in infants and young children under the age of three, with many later outgrowing the allergy. Soy is a common ingredient in many processed foods, baked goods, condiments, and other products such as infant formula. Cross contamination with other soy-containing foods is very common; therefore, it can be quite challenging to avoid.
Treatment for Soy Allergy
At Franklin Acupuncture, we specialize in a treatment for soy allergy called Soliman Auricular Allergy Treatment (SAAT). SAAT was developed by Dr. Nader Soliman, an innovator in the field of auricular (ear) acupuncture. Compared to immunotherapies and other holistic therapies, SAAT has been found to provide the most effective results. Ultimately, the outcome of receiving SAAT for soy allergy is complete elimination of the allergic reactions. We provide soy allergy treatment for patients in Tennessee and surrounding areas such as Kentucky, Mississippi, Alabama, Georgia, Indiana, and Illinois.
In conventional medicine, there are several options to mitigate the severity of reactions, such as avoidance, immunotherapy (oral immunotherapy, sublingual immunotherapy), epinephrine, over-the-counter antihistamines (Allegra, Claritin, Benadryl, etc) and prescribed antihistamines (Xolair). Immunotherapies for soy allergy require an extended period of time to desensitize the patient. They also require that the patient is exposed to soy at small incremental doses. Epinephrine is intended to stop severe reactions once they have begun; it does not stop the reactions from occurring in the first place.
Elimination of soy allergy utilizing SAAT does not require the patient to be exposed to the allergen. SAAT also does not require an extended period of time to address the soy allergy. Depending on what is found at the initial evaluation, the length of treatment is three to ten weeks.
At Franklin Acupuncture, we understand the seriousness of soy allergy. Our practitioner determines whether or not each patient has experienced anaphylactic shock to soy. If the patient has experienced anaphylactic shock, direct re-exposure instructions will not be provided. In this case, the intention of the treatment is to reduce the risk of incidental reactions to cross contamination, physical contact, or fumes.
Click below for more information about the allergy treatment process:
These statements have not been evaluated by the Food and Drug Administration. Any services or products are not intended to diagnose, treat, cure, or prevent any disease.
